Published in Vaccine Weekly, April 25th, 2012
"This study was undertaken to evaluate the immunogenicity and reactogenicity of Kinrix ™ when co-administered with MMR (M-M-RII ®, Merck & Co.) and Varivax ™ (Merck & Co.) in 4-6 year old children. Phase...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.